Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Mantel

Showing results (51-60 of 284) with videos related to

Pageof 29
Sort By:
Drug Safety|August 7, 2013
Adverse events during treatment of drug-resistant tuberculosis: a comparison between patients with or without human immunodeficiency virus co-infectionEvans Sagwa, Nunurai Ruswa, Jean Paul Musasa, et al.
Laryngo- Rhino- Otologie|February 1, 1996
[Fatal complications in tracheotomized children]N Kleinsasser, A Merkenschlager, C Schröter, et al.
Progress in Pediatric Surgery|January 1, 1991
Tracheal stenosis by innominate artery compression in infants: surgical treatment in 35 casesT Schuster, W C Hecker, E Ring-Mrozik, et al.
BMJ (Clinical Research Ed.)|February 28, 2024
Added benefit and revenues of oncology drugs approved by the European Medicines Agency between 1995 and 2020: retrospective cohort studyFrancine Brinkhuis, Wim G Goettsch, Aukje K Mantel-Teeuwisse, et al.
Journal of Pharmaceutical Policy and Practice|November 23, 2017
Availability, prices and affordability of UN Commission's lifesaving medicines for reproductive and maternal health in UgandaDenis Kibira, Freddy Eric Kitutu, Gemma Buckland Merrett, et al.
The Pediatric Infectious Disease Journal|April 10, 2025
Commentary: Pediatric HIV Treatment: Nurturing Access Through Health Facility Availability and Stock-out MonitoringTom G Jacobs, Gaby I Ooms, Aukje K Mantel-Teeuwisse, et al.
BMJ (Clinical Research Ed.)|February 29, 2024
High cost oncology drugs without proof of added benefit are burdening health systemsFrancine Brinkhuis, Wim G Goettsch, Aukje K Mantel-Teeuwisse, et al.
Bildgebung = Imaging|January 1, 1991
[Nuclear magnetic resonance tomography of children's thorax]T Vogl, C Wilimzig, K Mantel, et al.
Zeitschrift Fur Kinderchirurgie : Organ Der Deutschen, Der Schweizerischen Und Der Osterreichischen Gesellschaft Fur Kinderchirurgie = Surgery in Infancy and Childhood|April 1, 1990
[Tracheal compression by the brachiocephalic trunk in infants--surgical treatment of 30 cases]T Schuster, W C Hecker, E Ring-Mrozik, et al.
Health Policy (Amsterdam, Netherlands)|January 11, 2014
Personalised medicine as a challenge for public pricing and reimbursement authorities – A survey among 27 European countries on the example of trastuzumabC Leopold, S Vogler, C Habl, et al.
Pageof 29

Showing results (51-60 of 284) with videos related to

Sort By:
Pageof 29
Drug Safety|August 7, 2013
Adverse events during treatment of drug-resistant tuberculosis: a comparison between patients with or without human immunodeficiency virus co-infectionEvans Sagwa, Nunurai Ruswa, Jean Paul Musasa, et al.
Laryngo- Rhino- Otologie|February 1, 1996
[Fatal complications in tracheotomized children]N Kleinsasser, A Merkenschlager, C Schröter, et al.
Progress in Pediatric Surgery|January 1, 1991
Tracheal stenosis by innominate artery compression in infants: surgical treatment in 35 casesT Schuster, W C Hecker, E Ring-Mrozik, et al.
BMJ (Clinical Research Ed.)|February 28, 2024
Added benefit and revenues of oncology drugs approved by the European Medicines Agency between 1995 and 2020: retrospective cohort studyFrancine Brinkhuis, Wim G Goettsch, Aukje K Mantel-Teeuwisse, et al.
Journal of Pharmaceutical Policy and Practice|November 23, 2017
Availability, prices and affordability of UN Commission's lifesaving medicines for reproductive and maternal health in UgandaDenis Kibira, Freddy Eric Kitutu, Gemma Buckland Merrett, et al.
The Pediatric Infectious Disease Journal|April 10, 2025
Commentary: Pediatric HIV Treatment: Nurturing Access Through Health Facility Availability and Stock-out MonitoringTom G Jacobs, Gaby I Ooms, Aukje K Mantel-Teeuwisse, et al.
BMJ (Clinical Research Ed.)|February 29, 2024
High cost oncology drugs without proof of added benefit are burdening health systemsFrancine Brinkhuis, Wim G Goettsch, Aukje K Mantel-Teeuwisse, et al.
Bildgebung = Imaging|January 1, 1991
[Nuclear magnetic resonance tomography of children's thorax]T Vogl, C Wilimzig, K Mantel, et al.
Zeitschrift Fur Kinderchirurgie : Organ Der Deutschen, Der Schweizerischen Und Der Osterreichischen Gesellschaft Fur Kinderchirurgie = Surgery in Infancy and Childhood|April 1, 1990
[Tracheal compression by the brachiocephalic trunk in infants--surgical treatment of 30 cases]T Schuster, W C Hecker, E Ring-Mrozik, et al.
Health Policy (Amsterdam, Netherlands)|January 11, 2014
Personalised medicine as a challenge for public pricing and reimbursement authorities – A survey among 27 European countries on the example of trastuzumabC Leopold, S Vogler, C Habl, et al.
Pageof 29